Smart oral insulin therapy

Oral insulin therapy is always viewed as the holy grail of diabetes management. In this issue of Matter, Tao and colleagues developed a glucose-responsive oral insulin nanoplatform to achieve effective glycemic control and reduce the dosing frequency to once a day in type 1 diabetic mice.